EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access

Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis

Angelo Oliva iD, Anna Maria Ioppolo iD, Mauro Chiarito, Alberto Cremonesi, Alessia Azzano, Eligio Miccichè iD, Andrea Mangiameli iD, Francesco Ariano iD, Giuseppe Ferrante iD, Bernhard Reimers iD, Philippe Garot iD, Nicolas Amabile iD und 4 weitere

Journal of the American Heart Association · 20.08.2024 · 13 (16)

DOI: 10.1161/jaha.124.034815 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the American Heart Association, erschienen am 20.08.2024. Verfasst von Angelo Oliva und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department Humanitas Gavazzeni Hospital Bergamo Italy. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Left Atrial Appendage Closure. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Percutaneous left atrial appendage closure (LAAC) has been suggested as an alternative to long‐term oral anticoagulation for nonvalvular atrial fibrillation, but comparative data remain scarce. We aimed to assess ischemic and bleeding outcomes of LAAC compared with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) for the prevention of cardioembolic events in patients with atrial fibrillation. Methods and Results Embase and MEDLINE were searched for randomized trials comparing LAAC, VKAs, and DOACs. The primary efficacy end point was any stroke or systemic embolism. Treatment effects were calculated from a network meta‐analysis and ranked according to the surface under the cumulative ranking curve. Seven trials and 73 199 patients were included. The risk of the primary end point was not statistically different between LAAC versus VKAs (odds ratio [OR], 0.92 [95% CI, 0.62–1.50]) and LAAC versus DOACs (OR, 1.11 [95% CI, 0.71–1.73]). LAAC and DOACs resulted in similar risk of major or minor (OR, 0.93 [95% CI, 0.61–1.42]) and major bleeding (OR, 0.92 [95% CI, 0.58–1.46]); however, after exclusion of procedural bleeding, bleeding risk was significantly lower in those undergoing LAAC. Both LAAC and DOACs reduced the risk of all‐cause death compared with VKAs (LAAC versus VKAs: OR, 0.70 [95% CI, 0.53–0.91]; DOACs versus VKAs: OR, 0.90 [95% CI, 0.85–0.95], respectively). DOACs ranked as the best treatment for stroke or systemic embolism prevention (66.9%) and LAAC for reducing major bleeding (63.9%) and death (96.4%).

Conclusions

As a nonpharmacological alternative to oral anticoagulation for atrial fibrillation, LAAC showed similar efficacy and safety compared with VKAs or DOACs. Prospective confirmation from larger studies is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAtrial FibrillationLeft Atrial Appendage ClosureHumansAdministration, OralHemorrhageRisk FactorsStrokeTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationbleedingleft atrial appendage closureoral anticoagulationstroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Cardiovascular Department Humanitas Gavazzeni Hospital Bergamo Italy.
  • Department of Biomedical Sciences Humanitas University Pieve Emanuele MI Italy.
  • Cardio Center Humanitas Clinical and Research Hospital IRCCS Rozzano Italy.
  • Institut Cardiovasculaire Paris Sud (ICPS), Hôpital Privé Jacques Cartier Ramsay-Santé Massy France.
  • The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY USA.

ORCID-Profile: Angelo Oliva, Anna Maria Ioppolo, Eligio Miccichè, Andrea Mangiameli, Francesco Ariano, Giuseppe Ferrante, Bernhard Reimers, Philippe Garot, Nicolas Amabile, Roxana Mehran, Gianluigi Condorelli, Giulio Stefanini, Davide Cao

Zitieren

APA

Oliva, A., Ioppolo, A. M., Chiarito, M., Cremonesi, A., Azzano, A., Miccichè, E., Mangiameli, A., Ariano, F., Ferrante, G., Reimers, B., Garot, P., Amabile, N., Mehran, R., Condorelli, G., Stefanini, G., & Cao, D. (2024). Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis. Journal of the American Heart Association, 13(16). https://doi.org/10.1161/jaha.124.034815

Vancouver

Oliva A, Ioppolo AM, Chiarito M, Cremonesi A, Azzano A, Miccichè E, et al. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis. Journal of the American Heart Association. 2024;13(16). doi:10.1161/jaha.124.034815

BibTeX
@article{Oliva2024,
  author = {Oliva, Angelo and Ioppolo, Anna Maria and Chiarito, Mauro and Cremonesi, Alberto and Azzano, Alessia and Miccichè, Eligio and Mangiameli, Andrea and Ariano, Francesco and Ferrante, Giuseppe and Reimers, Bernhard and Garot, Philippe and Amabile, Nicolas and Mehran, Roxana and Condorelli, Gianluigi and Stefanini, Giulio and Cao, Davide},
  title = {Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {16},
  doi = {10.1161/jaha.124.034815}
}
Kostenlos starten →